Neodopasol

Neodopasol may be available in the countries listed below.

Ingredient matches for Neodopasol

Benserazide

Benserazide hydrochloride (a derivative of Benserazide) is reported as an ingredient of Neodopasol in the following countries:

• Japan

Levodopa

Levodopa is reported as an ingredient of Neodopasol in the following countries:

• Japan

International Drug Name Search

Salmotonin

Salmotonin may be available in the countries listed below.

Ingredient matches for Salmotonin

Calcitonin

Calcitonin is reported as an ingredient of Salmotonin in the following countries:

• Japan

International Drug Name Search

Colircusi Atropina

Colircusi Atropina may be available in the countries listed below.

Ingredient matches for Colircusi Atropina

Atropine

Atropine sulfate (a derivative of Atropine) is reported as an ingredient of Colircusi Atropina in the following countries:

• Portugal


• Spain

International Drug Name Search

Pipotiazina Dosa

Pipotiazina Dosa may be available in the countries listed below.

Ingredient matches for Pipotiazina Dosa

Pipotiazine

Pipotiazine is reported as an ingredient of Pipotiazina Dosa in the following countries:

• Argentina

International Drug Name Search

Decliten

Decliten may be available in the countries listed below.

Ingredient matches for Decliten

Prazosin

Prazosin hydrochloride (a derivative of Prazosin) is reported as an ingredient of Decliten in the following countries:

• Argentina

International Drug Name Search

Bisoprolol Lek

Bisoprolol Lek may be available in the countries listed below.

Ingredient matches for Bisoprolol Lek

Bisoprolol

Bisoprolol fumarate (a derivative of Bisoprolol) is reported as an ingredient of Bisoprolol Lek in the following countries:

• Croatia (Hrvatska)

International Drug Name Search

Cliofar

Cliofar may be available in the countries listed below.

Ingredient matches for Cliofar

Clindamycin

Clindamycin hydrochloride (a derivative of Clindamycin) is reported as an ingredient of Cliofar in the following countries:

• Dominican Republic

International Drug Name Search

Acetazolamide

In some countries, this medicine may only be approved for veterinary use.

In the US, Acetazolamide (acetazolamide systemic) is a member of the following drug classes: carbonic anhydrase inhibitor anticonvulsants, carbonic anhydrase inhibitors and is used to treat Edema, Epilepsy, Glaucoma, Hydrocephalus, Mountain Sickness / Altitude Sickness, Pseudotumor Cerebri and Seizure Prevention.

US matches:

• Acetazolamide


• Acetazolamide Solution


• Acetazolamide Sustained-Release Capsules


• Acetazolamide Sodium


• Acetazolamide Capsules


• Acetazolamide Tablets

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

S01EC01

CAS registry number (Chemical Abstracts Service)

0000059-66-5

Chemical Formula

C4-H6-N4-O3-S2

Molecular Weight

222

Therapeutic Categories

Diuretic agent

Carbonic anhydrase inhibitor

Chemical Names

2-Acetamido-1,3,4-thiadiazole-5-sulfonamide

Acetamide, N-[5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl]-

N-(5-Sulfamoyl-1,3,4-thiadiazol-2-yl)acetamid

Foreign Names

• Acetazolamidum (Latin)
• Acetazolamid (German)
• Acétazolamide (French)
• Acetazolamida (Spanish)

Generic Names

• Acetazolamide (OS: BAN, JAN)
• Acétazolamide (OS: DCF)
• RP 5172 (IS)
• Acetazolamid (PH: Ph. Eur. 6)
• Acetazolamide (PH: BP 2010, JP XV, Ph. Int. 4, USP 32, Ph. Eur. 6)
• Acétazolamide (PH: Ph. Eur. 6)
• Acetazolamidum (PH: Ph. Int. 4, Ph. Eur. 6)
• Acetazolamide Sodium (PH: USP 24)

Brand Names

• Acemit
  Medphano, Germany



• Acemox
  Acme, Bangladesh



• Acetadiazol
  Grin, Mexico



• Acetak
  Akorn, Peru



• Acetazolamid Pharmedic
  Pharmedic, Vietnam



• Acetazolamid
  Agepha, Austria; Remedica, Cyprus



• Acetazolamida L.CH.
  Chile, Chile



• Acetazolamida
  AC Farma, Peru; Farmindustria, Peru; Mintlab, Chile



• Acetazolamide Sandoz
  Sandoz, Netherlands



• Acetazolamide Tablets
  Lannett, United States; Mutual, United States; Taro, United States; Watson, United States



• Acetazolamide
  Blaskov, Colombia; IFET, Greece; Mutual, United States; Teva USA, United States



• Apo-Acetazolamida
  Apotex, Peru



• Apo-Acetazolamide
  Apotex, Canada; Apotex, Hong Kong; Apotex, Singapore; Apotex, Vietnam



• Azol
  New Chem & Pharm, Taiwan



• Azomid
  Adcock Ingram Pharmaceuticals, South Africa



• Carbinib
  Edol, Portugal



• Défiltran
  CSP, France



• Diacarb
  Polpharma, Georgia; Polpharma, Lithuania; Polpharma, Latvia; Polpharma, Russian Federation



• Diamox Depot
  Goldshield, Iceland; Goldshield, Norway



• Diamox
  Abcur, Sweden; Cyanamid, Ethiopia; Duramed, United States; Goldshield, Austria; Goldshield, Germany; Goldshield, Denmark; Goldshield, United Kingdom; Goldshield, Ireland; Goldshield, Iceland; Goldshield, Luxembourg; Goldshield, Malta; Goldshield, Norway; Healthcare Logistics, New Zealand; Lederle, Israel; Medical Intertrade, Croatia (Hrvatska); MPI, Belgium; Pharmafrica, South Africa; Procaps, Colombia; Sanofi-Aventis, France; Sanwa Kagaku, Japan; Sigma, Australia; Teofarma, Italy; Theraplix, Tunisia; Vifor, Switzerland; Wyeth, Argentina; Wyeth, India; Wyeth, Peru; Wyeth, Thailand



• Diamox (veterinary use)
  Goldshield, United Kingdom



• Diazomid
  Sanofi-Aventis, Turkey



• Diluran
  Zentiva, Czech Republic; Zentiva, Slovakia



• Diuramid
  Polpharma, Poland



• Edemox
  Chiesi, Spain



• Ederen
  Terapia, Romania



• Edimox
  Gaco, Bangladesh



• Glaupax
  Omnivision, Switzerland; Omnivision, Germany; Orion, United Arab Emirates; Orion, Bahrain; Orion, Egypt; Orion, Ireland; Orion, Jordan; Orion, Kuwait; Orion, Lebanon



• Huma-Zolamide
  Teva, Hungary



• Oculten
  Acromax, Dominican Republic; Acromax, El Salvador



• Ödemin
  Santen, Finland



• Uramox
  Taro, Israel



• Acetazolamide Sodium
  Bedford, United States; Hospira, United States



• Acetazolamide
  Ben Venue, Israel



• Diamox
  Duramed, United States; Goldshield, Austria; Goldshield, Germany; Goldshield, Ireland; Goldshield, Netherlands; Healthcare Logistics, New Zealand; MPI, Belgium; Vifor, Switzerland; Wyeth, Bahrain



• Glaumox
  Phebra, Australia



• Vetamox (veterinary use)
  Fort Dodge Animale Health, United States

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Staxyn

Staxyn is a brand name of vardenafil, approved by the FDA in the following formulation(s):

STAXYN (vardenafil hydrochloride - tablet, orally disintegrating; oral)

• 
  Manufacturer: BAYER HLTHCARE
  
  Approval date: June 17, 2010
  
  Strength(s): 10MG ^[RLD]

Has a generic version of Staxyn been approved?

No. There is currently no therapeutically equivalent version of Staxyn available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Staxyn. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
  Patent 6,362,178
  Issued: March 26, 2002
  Inventor(s): Ulrich; Niewöhner & Mazen; Es-Sayed & Helmut; Haning & Thomas; Schenke & Karl-Heinz; Schlemmer & Jörg; Keldenich & Erwin; Bischoff & Elisabeth; Perzborn & Klaus; Dembowsky & Peter; Serno & Marc; Nowakowski
  Assignee(s): Bayer Aktiengesellschaft
  The 2-phenyl-substituted imidazotriazinones having short, unbranched alkyl radicals in the 9-position are prepared from the corresponding 2-phenyl-imidazotriazinones by chlorosulphonation and subsequent reaction with the amines. The compounds inhibit cGMP-metabolizing phosphodiesterases and are suitable for use as active compounds in pharmaceuticals, for the treatment of cardiovascular and cerebrovascular disorders and/or disorders of the urogenital system, in particular for the treatment of erectile dysfunction.
  
  Patent expiration dates:
  
  
  • October 31, 2018
    
    ✓ 
    Patent use: TREATMENT OF ERECTILE DYSFUNCTION
  
  



• 
  2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
  Patent 7,696,206
  Issued: April 13, 2010
  Inventor(s): Niewöhner; Ulrich & Es-Sayed; Mazen & Haning; Helmut & Schenke; Thomas & Schlemmer; Karl-Heinz & Keldenich; Jorg & Bischoff; Erwin & Perzborn; Elisabeth & Dembowsky; Klaus & Serno; Peter & Nowakowski; Marc
  Assignee(s): Bayer Schering Pharma Aktiengesellschaft
  The application claims a compound of the formula or a salt, a hydrate, or a hydrate of a salt thereof. The compounds inhibit cGMP-metabolizing phosphodiesterases and are suitable for use as active compounds in pharmaceuticals, for the treatment of erectile dysfunction.
  
  Patent expiration dates:
  
  
  • October 31, 2018
    
    ✓ 
    Patent use: TREATMENT OF ERECTILE DYSFUNCTION
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • June 17, 2013 - NEW DOSAGE FORM
  
  

See also...

• Staxyn Consumer Information (Drugs.com)
• Staxyn Orally Disintegrating Tablets Consumer Information (Wolters Kluwer)
• Staxyn Consumer Information (Cerner Multum)
• Staxyn Advanced Consumer Information (Micromedex)
• Vardenafil Consumer Information (Wolters Kluwer)
• Vardenafil Orally Disintegrating Tablets Consumer Information (Wolters Kluwer)
• Vardenafil Consumer Information (Cerner Multum)
• Vardenafil Advanced Consumer Information (Micromedex)
• Vardenafil Hydrochloride AHFS DI Monographs (ASHP)

Ecumox

Ecumox may be available in the countries listed below.

Ingredient matches for Ecumox

Amoxicillin

Amoxicillin is reported as an ingredient of Ecumox in the following countries:

• Ecuador

International Drug Name Search

M5050

M5050 may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for M5050

Diprenorphine

Diprenorphine hydrochloride (a derivative of Diprenorphine) is reported as an ingredient of M5050 in the following countries:

• South Africa

International Drug Name Search